| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0054 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |